DRUG

EPA

1 hypothesis across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for EPA

Rheumatoid arthritis 1

Mediator Outcome Score Tier Lit. status Trial
STAT3 prurigo nodularis 0.208 Mid novel signal none

Clinical trials

200 registered trials for EPA

Source: ClinicalTrials.gov